Moderna
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2010-01-01
- Employees
- 5.6K
- Market Cap
- $30.3B
- Website
- http://www.modernatx.com
- Introduction
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
U.S. Restarts Free COVID Test Program
U.S. restarts free COVID test program, offering 4 free tests per household via COVIDTests.gov. Tests detect current variants and are usable through year-end. Over 900 million tests have been distributed. At-home tests provide results in 30 minutes or less, applicable to vaccinated and unvaccinated individuals. Vaccines, including mRNA and Novavax options, are also available, targeting dominant strains.
GSK ceases HSV vaccine - a chance for Moderna and BioNTech
GSK discontinued its HSV therapeutic vaccine, GSK3943104, after a Phase I/II trial failure, highlighting challenges in developing a vaccine for genital herpes. Moderna and BioNTech are now leading contenders with mRNA-based HSV vaccine candidates in development.
Biomanufacturing for the Next Pandemic
Vaccine manufacturing is critical for future pandemic preparedness, requiring global collaboration and optimized processes. Inequitable distribution of COVID-19 vaccines highlights the need for manufacturing in low- and middle-income countries. Challenges include diverse vaccine platforms and regional infrastructure differences, necessitating significant process optimization. Collaborative efforts like BioNTech/CEPI in Rwanda aim to address these issues.
Free COVID Tests Back Again by End of September
U.S. government offers another round of free COVID tests by end of September, available at COVIDTests.gov. Over 900 million tests have been distributed. At-home tests provide results within 30 minutes. Vaccines, including strain-specific formulations, are also available.
Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I
UK-based Vicebio raised $100m in Series B funding led by TCGX to advance its RSV and hMPV vaccine VXB-241 to Phase I trials, utilizing its 'molecular clamp' technology for enhanced immune response.
Related Clinical Trials:
PM Modi leads Tech CEOs Roundtable in New York, pushing for greater India-US cooperation
Prime Minister Narendra Modi held a roundtable with tech CEOs in New York to boost India-US cooperation in AI, Quantum Computing, Biotechnology, Life Sciences, IT, and Semiconductors. Modi emphasized India's potential as a global tech hub, inviting companies to co-develop, co-design, and co-produce in India. CEOs expressed interest in expanding investments and collaborations, highlighting India's innovation-friendly policies and rapid digital expansion.
Top Tech Firm CEOs Meet PM Modi In US - What They Discussed
PM Modi met CEOs from top tech firms in New York, discussing AI, quantum computing, semiconductors, and biotechnology. Bilateral meetings highlighted collaborations in chip manufacturing and AI innovation, with IBM's Watsonx platform integration in India.
PM Modi attends 'fruitful' roundtable meeting with tech CEOs in New York
PM Modi held a 'fruitful' roundtable with US tech CEOs in NY, discussing AI, quantum, biotech, computing, and semiconductors. He emphasized India's growth prospects, IP protection, and fostering tech innovation, aiming to make India a global hub for semiconductor manufacturing and a biotech powerhouse.
Roundtable talk with tech CEOs: PM Modi discusses India's growth and innovation prospects
PM Modi engaged with top US CEOs in NY, discussing tech collaborations in semiconductors, AI, quantum computing, and biotech, highlighting India's innovation strides and inviting US firms to leverage India's digital growth.
Modi US visit: PM attends tech CEO roundtable in New York, Google CEO Sundar Pichai ...
PM Narendra Modi engaged tech CEOs in New York, discussing collaborations in semiconductors, AI, quantum computing, and biotechnology, emphasizing India's role as a global innovation hub. He coined 'American-Indian spirit' as the new global AI force and thanked President Biden for his hospitality.
© Copyright 2024. All Rights Reserved by MedPath